Bayer Buying Sagmel OTC Brands For Eastern European, Central Asian Boost
This article was originally published in The Tan Sheet
Executive Summary
Bayer will "substantially increase" its OTC presence in Russia and other countries in the Commonwealth of Independent States with its acquisition of U.S. firm Sagmel's drug and nutritional supplement brands, according to the firms
You may also be interested in...
Open Russian OTC Market Would Come With Challenges
Expanding nonprescription drug sales in Russia from pharmacies to grocery stores would open doors to new sales, but the huge emerging market presents significant hurdles to firms looking to fully capitalize on the opportunity
Open Russian OTC Market Would Come With Challenges
Expanding nonprescription drug sales in Russia from pharmacies to grocery stores would open doors to new sales, but the huge emerging market presents significant hurdles to firms looking to fully capitalize on the opportunity
Open Russian OTC Market Would Come With Challenges
Expanding nonprescription drug sales in Russia from pharmacies to grocery stores would open doors to new sales, but the huge emerging market presents significant hurdles to firms looking to fully capitalize on the opportunity